Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | WSTWest Pharmaceutical Services IncFY2025 · Dec |
|---|---|
| Revenue | $3.07B |
| Revenue, yoy | +6.3% |
| Net income | $493.70M |
| Net income, yoy | +0.2% |
| Net margin | 16.1% |
| Free cash flow | $468.90M |
| FCF margin | 15.3% |
| EPS, diluted | $6.79 |
Add another company.